DSpace Repository

Browsing 02.National Laboratory Astana by Subject "breast cancer"

Browsing 02.National Laboratory Astana by Subject "breast cancer"

Sort by: Order: Results:

  • Anticancer effects of leech extract on breast cancer cells 
    Murzakhmetova, S.; Janzakova, D.; Mektepbayeva, D. (2016-05)
    Throughout the history of humanity, leech therapy appeared as a procedure in medicine all over the world. The very first use of leech in human treatment was mentioned in Eqypt 3500 years ago. In 2004, Food and Drug ...
  • ANTIPROLIFERATIVE AND CYTOTOXIC ACTIVITY OF GERANIACEAE PLANT EXTRACTS AGAINST FIVE TUMOR CELL LINES 
    Sergazy, Shynggys; Vetrova, Anastassiya; Orhan, Ilkay Erdogan; Deniz, Fatma Sezer Senol; Kahraman, Ahmet; Zhang, Jian-Ye; Aljofan, Mohamad (Future science, 2021)
    Several plant species of the genera Geranium and Erodium were extracted and screened against five tumor cell lines for their potential antitumor activities. Out of the tested species, four showed potential antitumor ...
  • Assessing reproducibility of matrix factorization methods in independent transcriptomes 
    Cantini, Laura; Kairov, Ulykbek; de Reynies, Aurelien; Barillot, Emmanuel; Radvanyi, Francois; Zinovyev, Andrei (OXFORD UNIV PRESS, 2019)
    Motivation Matrix factorization (MF) methods are widely used in order to reduce dimensionality of transcriptomic datasets to the action of few hidden factors (metagenes). MF algorithms have never been compared based on ...
  • Determination of HER-2/NEU Oncoprotein level in the serum of breast cancer patients 
    Eskendirova, S.; Sarina, N.; Zhylkibayev, A. (National Laboratory Astana, Nazarbayev University, 2017-09-15)
  • Results of the study of biological subtypes of breast cancer 
    Tailakov, B.B.; Tuleutaev, M.E.; Pirozhenko, O.P.; Gubskaya, E.B.; Orazbekov, B.S.; Balhozhaeva, A.A.; Zhukov, Y.; Rutzhanuly, I.R.; Omarov, M.H.; Makis, R.T.; Tusupbekov, E.H.; Ermagambetova, A.T. (National Laboratory Astana, NAZARBAYEV UNIVERSITY, 2016-05)
    Identification of biological subtypes of breast cancer using immunohistochemical tumor markers: ER and RP receptor, Ki67, Her-2 / neu is a modern criterion for the development of optimal therapies for the breast cancer.